A Yap

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.

F. Anthony Greco, Robert A. Figlin, Martin York et al. · Journal of Clinical Oncology · 1996 · 78 citations

Medicine, Oncology, Pharmacology +14

The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study

Michael Millward, Colin M. House, David D.L. Bowtell et al. · British Journal of Cancer · 2006 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase I/II trial of the oral mTOR-inhibitor everolimus (E) and imatinib mesylate (IM) in patients (pts) with gastrointestinal stromal tumor (GIST) refractory to IM: Study update

A. van Oosterom, Peter Reichardt, Jean‐Yves Blay et al. · Journal of Clinical Oncology · 2005 · 46 citations

Medicine, Oncology, Pharmacotherapy +16

A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C

Andres Virchis, K. Ganeshaguru, Dylan T. Jones et al. · The Hematology Journal · 2002 · 39 citations

Medicine, Hematology, Pharmacology +10

THE EFFECT OF SMOKING ON CAFFEINE ELIMINATION: IMPLICATIONS FOR ITS USE AS A SEMIQUANTITATIVE TEST OF LIVER FUNCTION

Therese L. Murphy, Carolyn McIvor, A Yap et al. · Clinical and Experimental Pharmacology and Physiology · 1988 · 32 citations

Pharmacy, Pharmacokinetics, Pharmacology +17